RESUMO
The central aim of this study was to investigate hormones as a predictor of individual vulnerability or resiliency on emotion processing tasks following one night of sleep restriction. The restriction group was instructed to sleep 3 a.m.-7 a.m. (13 men, 13 women in follicular phase, 10 women in luteal phase of menstrual cycle), and a control group slept 11 p.m.-7 a.m. (12 men, 12 follicular women, 12 luteal women). Sleep from home was verified with actigraphy. Saliva samples were collected on the evening prior to restriction, and in the morning and afternoon following restriction, to measure testosterone, estradiol, and progesterone. In the laboratory, event-related potentials (ERPs) were recorded during presentation of images and faces to index neural processing of emotional stimuli. Compared to controls, sleep-restricted participants had a larger amplitude Late Positive Potential (LPP) ERP to positive vs neutral images, reflecting greater motivated attention towards positive stimuli. Sleep-restricted participants were also less accurate categorizing sad faces and exhibited a larger N170 to sad faces, reflecting greater neural reactivity. Sleep-restricted luteal women were less accurate categorizing all images compared to control luteal women, and progesterone was related to several outcomes. Morning testosterone in men was lower in the sleep-restricted group compared to controls; lower testosterone was associated with lower accuracy to positive images, a greater difference between positive vs neutral LPP amplitude, and lower accuracy to sad and fearful faces. In summary, women higher in progesterone and men lower in testosterone were more vulnerable to the effects of sleep restriction on emotion processing tasks. This study highlights a role for sex and sex hormones in understanding individual differences in vulnerability to sleep loss.
RESUMO
Standard anatomical textbooks describe the insertion of the subscapularis tendon on to the lesser tuberosity of the humerus. The transverse humeral ligament is also described at this level, as a band of tissue attached to the greater and lesser tuberosities, overlying the long tendon of biceps as it emerges from the capsule of the shoulder joint. The shoulder is a notorious site for anatomical variation but until recently little has been published with regard to the tendon of subscapularis. In this study, we illustrate that considerable variation in the insertion site of the tendon of subscapularis can be demonstrated using magnetic resonance imaging and that only 20% conform to the classic textbook description. In addition, a distinct transverse humeral ligament was identifiable in only a minority of shoulders examined (36%).
Assuntos
Imageamento por Ressonância Magnética , Escápula/anatomia & histologia , Tendões/anatomia & histologia , Feminino , Humanos , Úmero/anatomia & histologia , Ligamentos/anatomia & histologia , Masculino , Pessoa de Meia-Idade , Músculo Esquelético/anatomia & histologia , Articulação do Ombro/anatomia & histologiaRESUMO
AIM: To document the skin manifestations of renal transplant recipients. METHODS: The findings in 52 patients (27 males; mean age 43.5 yr; range 22-74 yr; SD 12.0) with a stable renal transplant for a mean of 115.6 mth (range 3-258; SD 70.6). Thirty seven patients were on prednisone and azathioprine and 18 on prednisone, azathioprine and cyclosporin. RESULTS: Including prior observations, 48 cutaneous malignancies were identified in nine patients, with the ratio of squamous cell to basal cell carcinoma being 1.2:1. No metastases were detected. Actinic keratoses were present in 20 patients and tended to be multiple and present on sun exposed skin. A wide range of nonneoplastic lesions was documented, including warts in 75%. Human papillomavirus was isolated from 43% of warts. CONCLUSIONS: Renal transplant recipients require regular skin examination. Patients with high recreational or work related sun exposure prior to, or after transplantation, and those who have had a previous skin malignancy, should be identified as high risk patients for skin cancer and have regular dermatological follow up.
Assuntos
Terapia de Imunossupressão/efeitos adversos , Transplante de Rim , Dermatopatias/epidemiologia , Adulto , Idoso , Carcinoma in Situ/epidemiologia , Carcinoma de Células Escamosas/epidemiologia , Feminino , Humanos , Ceratose/epidemiologia , Ceratose/etiologia , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Nova Zelândia , Fatores de Risco , Dermatopatias/etiologia , Dermatopatias Infecciosas/epidemiologia , Neoplasias Cutâneas/epidemiologia , Luz Solar/efeitos adversos , Verrugas/epidemiologia , Verrugas/virologiaRESUMO
Iohexol (Omnipaque 350) and iopamidol (Isovue 370) are nonionic monomers; ioxaglate (Hexabrix 320) is an ionic dimer. We compared the nephrotoxicity of these three media by a prospective double-blind evaluation in 500 patients who underwent peripheral angiography during a 6-month period. Serum creatinine levels were determined before injection of the contrast medium and 72 hours after in 478 patients. In 308 (64%) patients there was an average increase in the serum creatinine level of 18.1 mumol/L after injection of an average volume of 123 ml of contrast medium. A subset of 80 patients who had an elevated baseline creatinine level (more than 110 mumol/L) had an average increase in the serum creatinine level of 40.45 mumol/L. Of patients who had arterial injections, 182 (72%) had an increase in serum creatinine level (20.7 mumol/L), but of those who had peripheral venous injections, only 43 (45%) had an elevated creatinine level (9.2 mumol/L), and of those who had central venous injections, 83 (63.8%) had an elevated level (17.0 mumol/L). In most patients elevation of the serum creatinine level was not of clinical importance. High-risk patients with an elevated serum creatinine level were found to be most vulnerable to contrast nephrotoxicity. Although mean differences were not statistically significant, there were consistent trends which suggested that ioxaglate was the least nephrotoxic of the three agents studied.
Assuntos
Iohexol/efeitos adversos , Iopamidol/efeitos adversos , Ácido Ioxáglico/efeitos adversos , Rim/efeitos dos fármacos , Injúria Renal Aguda/sangue , Injúria Renal Aguda/induzido quimicamente , Idoso , Angiografia , Creatinina/sangue , Diabetes Mellitus/sangue , Método Duplo-Cego , Feminino , Humanos , Injeções Intra-Arteriais , Ácido Ioxáglico/administração & dosagem , Masculino , Pessoa de Meia-Idade , Estudos ProspectivosRESUMO
Eighteen patients with chronic plaque psoriasis were investigated in two groups to determine the optimal contact time for the application of 2% anthralin, within the range immediate removal to removal at 20 min. It was found that clinical efficacy, assessed by times to plaque clearing, and side effects of treatment, i.e. erythema and staining, were independent of anthralin contact time. There seemed to be a relationship between erythema induction and skin type.
Assuntos
Antracenos/administração & dosagem , Antralina/administração & dosagem , Psoríase/tratamento farmacológico , Adolescente , Adulto , Idoso , Antralina/efeitos adversos , Antralina/uso terapêutico , Criança , Doença Crônica , Cor , Esquema de Medicação , Eritema/induzido quimicamente , Humanos , Pessoa de Meia-IdadeRESUMO
Terfenadine, a potent and non-sedative antihistamine, was shown to be effective in chronic idiopathic urticaria in a double-blind crossover placebo controlled trial. An oral twice daily 60 mg dose of terfenadine was given and itch and wheal parameters were assessed daily. Despite the overall effectiveness of terfenadine, a variable response was noted which was similar to that shown in previous studies with other antihistamines.
Assuntos
Compostos Benzidrílicos/uso terapêutico , Urticária/tratamento farmacológico , Adulto , Idoso , Compostos Benzidrílicos/efeitos adversos , Doença Crônica , Ensaios Clínicos como Assunto , Método Duplo-Cego , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Distribuição Aleatória , TerfenadinaRESUMO
An in vitro method for determination of the phototoxic action spectrum of benzanthrone was established using a cover slip-test tube culture system with mouse peritoneal macrophages. The action spectrum peaked between 380 and 400 nm with abrupt fall-off to either side. These findings correlate closely with both the absorption spectrum of benzanthrone and the clinical action spectrum of phototoxicity in humans.
Assuntos
Benzo(a)Antracenos/farmacologia , Macrófagos/efeitos dos fármacos , Animais , Sobrevivência Celular/efeitos dos fármacos , Sobrevivência Celular/efeitos da radiação , Dermatite de Contato/etiologia , Humanos , Técnicas In Vitro , Macrófagos/efeitos da radiação , Camundongos , Camundongos Endogâmicos ICR , Fotoquímica , EspectrofotometriaAssuntos
Penfigoide Gestacional/tratamento farmacológico , Complicações na Gravidez/tratamento farmacológico , Propanolaminas/uso terapêutico , Ritodrina/uso terapêutico , Dermatopatias Vesiculobolhosas/tratamento farmacológico , Adulto , Feminino , Humanos , Trabalho de Parto Prematuro/tratamento farmacológico , GravidezRESUMO
Polymorphonuclear leucocyte chemotaxis was investigated in 6 patients with active dermatitis herpetiformis in the untreated state and when under control with Dapsone. Control studies were undertaken in 7 healthy volunteers. No significant difference in chemotaxis was demonstrated between the active, treated and control groups. Furthermore, when Dapsone in physiological concentrations was added separately in all three groups there was no additional effect on chemotaxis. These results clearly show that polymorphonuclear leucocytes from active untreated dermatitis herpetiformis have normal chemotactic activity compared with those from the same patients in the treated state and controls. Additional Dapsone did not alter these findings.
Assuntos
Quimiotaxia de Leucócito/efeitos dos fármacos , Dapsona/uso terapêutico , Dermatite Herpetiforme/sangue , Adulto , Dapsona/farmacologia , Dermatite Herpetiforme/tratamento farmacológico , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , NeutrófilosRESUMO
Three middle-aged women treated with lithium carbonate for a manic-depressive illness have had complicating nephrogenic diabetes insipidus, renal tubular acidosis, acute reversible renal functional impairment in association with hypercalcaemia, or irreversible chronic renal damage. Renal toxicity developed in the presence of normal levels of lithium in the serum. The possibility of permanent renal damage as a result of long-term lithium therapy is of major concern.